Cargando…

Challenges of globalization of cancer drug trials- recruitment in LMICs, approval in HICs

Detalles Bibliográficos
Autores principales:	Gyawali, Bishal, Carson, Laura M., Berry, Scott, Moraes, Fabio Y.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9903727/ https://www.ncbi.nlm.nih.gov/pubmed/36777649 http://dx.doi.org/10.1016/j.lana.2021.100157

Ejemplares similares

Cancer drugs in LMICs: cheap but unaffordable
por: Gyawali, Bishal
Publicado: (2017)

Global HIV efforts need to focus on key populations in LMICs
por: Simbayi, Leickness C, et al.
Publicado: (2021)

COVID-19 in pregnancy: evidence from LMICs
por: Costa, Maria Laura, et al.
Publicado: (2022)

Intention to probe into the colonoscopy trial: Is it the procedure or the trial that failed?
por: Knopf, Kevin B., et al.
Publicado: (2022)

Challenges in Implementing Surveillance Tools of High-Income Countries (HICs) in Low Middle Income Countries (LMICs)
por: Jayatilleke, Kushlani
Publicado: (2020)

Approvals in 2021: dangling Accelerated Approvals, drug dosing, new approvals and beyond
por: Lemery, Steven, et al.
Publicado: (2022)

Steroids or intravenous immunoglobulin as first line in MIS-C in LMICs
por: Crosby, Laura, et al.
Publicado: (2021)

Addressing the Mental Health Challenges of Cancer Care Workers in LMICs During the Time of the COVID-19 Pandemic
por: Datta, Soumitra S., et al.
Publicado: (2020)

COVID-19 vaccines for children in LMICs: another equity issue
por: Kampmann, Beate, et al.
Publicado: (2021)

COVID-19 and cancer: do we really know what we think we know?
por: Robinson, Andrew G., et al.
Publicado: (2020)

Regulatory and clinical consequences of negative confirmatory trials of accelerated approval cancer drugs: retrospective observational study
por: Gyawali, Bishal, et al.
Publicado: (2021)

Improving nutrition and immunity with dry chain and integrated pest management food technologies in LMICs
por: Dahal, Peetambar, et al.
Publicado: (2020)

Same Data; Different Interpretations
por: Gyawali, Bishal, et al.
Publicado: (2016)

Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval
por: Cherla, Avi, et al.
Publicado: (2021)

Evaluating the evidence behind the surrogate measures included in the FDA's table of surrogate endpoints as supporting approval of cancer drugs
por: Gyawali, Bishal, et al.
Publicado: (2020)

Gender and the COVID-19 pandemic: Multinational research indicate that we must support and compensate LMIC women's leadership in crises
por: Raj, Anita
Publicado: (2022)

Local distribution infrastructure and robust vaccine manufacturing facilities in LMICs should be prioritised to tackle ongoing and future pandemic risk
por: Reza, Hasan Mahmud, et al.
Publicado: (2023)

Cost-effectiveness versus treatment effectiveness: A radiation oncologist's dilemma in low-income and middle-income countries (LMIC)
por: Iyer, Priya
Publicado: (2022)

Rationale to continue approving placebo-controlled COVID-19 vaccine trials in LMICs
por: Sisa, Ivan, et al.
Publicado: (2021)

Is Aducanumab for LMICs? Promises and Challenges
por: Gunawardena, Illangage P. C., et al.
Publicado: (2021)

The case for SABR as the global standard for non-operable early-stage non-small cell lung cancer
por: Mutsaers, Adam, et al.
Publicado: (2022)

Final approval for corticosteroids in severe CAP? For sure, in septic shock
por: Martin-Loeches, Ignacio, et al.
Publicado: (2023)

Overview of Services for Autism Spectrum Disorders (ASD) in Low- and Middle-Income Countries (LMICs) and among Immigrants and Minority Groups in High-Income Countries (HICs)
por: Samadi, Sayyed Ali
Publicado: (2022)

Solving the global challenge of adolescent mental ill-health
por: Cluver, Lucie
Publicado: (2020)

Legal determinants of health: facing global health challenges
por: Lo, Selina, et al.
Publicado: (2019)

Oncology approvals in 2020: a year of firsts in the midst of a pandemic
por: Amiri-Kordestani, Laleh, et al.
Publicado: (2021)

Accelerating evidence gathering and approval of precision medicine therapies: the FDA takes aim at rare mutations
por: Issa, Amalia M., et al.
Publicado: (2018)

Machine learning-based global maps of ecological variables and the challenge of assessing them
por: Meyer, Hanna, et al.
Publicado: (2022)

Triumphs, trials, and tribulations of the global response to MERS coronavirus
por: McNabb, Scott J N, et al.
Publicado: (2014)

‘What puts the ‘Hic’ into Hiccups?’
por: Seifi, Ali, et al.
Publicado: (2022)

A new recruit for the army of the men of death
por: Petsko, Gregory A
Publicado: (2003)

Shifting drug markets in North America - a global crisis in the making?
por: Meyer, Maximilian, et al.
Publicado: (2023)

What Global Oncology Needs: Mutual Learning and More Funding
por: Gyawali, Bishal, et al.
Publicado: (2018)

The Global Fund in China: success beyond the numbers
por: Minghui, Ren, et al.
Publicado: (2015)

Training General Practitioners in Oncology: Lessons Learned From a Cross-Sectional Survey of GPOs in Canada
por: Gyawali, Bishal, et al.
Publicado: (2023)

Addressing the Global Challenges of COVID-19 and Other Pulmonary Diseases with Microfluidic Technology
por: Xie, Yuliang, et al.
Publicado: (2022)

The International Hundred Thousand Plus Cohort Consortium: integrating large-scale cohorts to address global scientific challenges
por: Manolio, Teri A, et al.
Publicado: (2020)

Biobanking in LMIC settings for infectious diseases: Challenges and enablers()
por: Ezzat, Sameera, et al.
Publicado: (2022)

Cancer Therapy Approval Timings, Review Speed, and Publication of Pivotal Registration Trials in the US and Europe, 2010-2019
por: Lythgoe, Mark P., et al.
Publicado: (2022)

Cardiac cachexia: hic et nunc
por: Loncar, Goran, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_fltrs714q9a8n69pak7eumf189